Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury.

Synthetic surfactants allow examination of the effects of specific components of natural surfactant. To determine whether surfactant containing apoprotein C, dipalmitoyl-phosphatidylcholine, phosphatidylglycerol, and palmitic acid restores gas-exchanging function in acute lung injury (ALI), we administered such surfactant (in doses of 50 or 100 mg/kg and in volumes from 1 to 6 ml/kg) or phospholipid (PL) alone, by intratracheal instillation, to pigs with ALI induced by massive saline lavage. Animals ventilated with 100% O(2) and receiving 1, 2, 4, or 6 ml/kg of 50 mg/kg recombinant surfactant apoprotein C (rSP-C) surfactant or 2 ml/kg of 50 mg/kg PL (control) had mean arterial PO(2) values, 4 h after treatment, of 230, 332, 130, 142, or 86 Torr, respectively. Animals receiving 1, 2, or 4 ml/kg of 100 mg/kg rSP-C surfactant or 2 ml/kg of 100 mg/kg PL (control) had mean arterial PO(2) values of 197, 214, 148, or 88 Torr, respectively. Surfactant PL distribution was homogeneous. Hyaline membrane formation was reduced in treated animals. Thus, in this model of ALI, rSP-C with PL has the capacity to improve gas exchange and possibly modify lung injury.

[1]  A. Jobe,et al.  Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. , 1998, American journal of respiratory and critical care medicine.

[2]  R. Parker,et al.  Effect of volume recruitment on response to surfactant treatment in rabbits with lung injury. , 1997, American journal of respiratory and critical care medicine.

[3]  K. Steinberg,et al.  Bovine surfactant therapy for patients with acute respiratory distress syndrome. , 1997, American journal of respiratory and critical care medicine.

[4]  R. Spragg,et al.  Pathology of the surfactant system of the mature lung. , 1997, American journal of respiratory and critical care medicine.

[5]  Ram N. Singh,et al.  Exogenous Surfactant Therapy for Pediatric Patients with Acute Respiratory Distress Syndrome , 1997 .

[6]  K. Yukitake,et al.  Lung function in premature rabbits treated with recombinant human surfactant protein-C. , 1996, American journal of respiratory and critical care medicine.

[7]  A. Zaritsky,et al.  Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. , 1996, Critical care medicine.

[8]  A. H. El-Astal,et al.  Wavelength dependent refractive effects and Stark broadening in laser‐induced YBa2Cu3Ox plasma plumes , 1996 .

[9]  W. Seeger,et al.  Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. , 1996, American journal of respiratory and critical care medicine.

[10]  A. Anzueto,et al.  Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome , 1996 .

[11]  J. Goffin,et al.  Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury. , 1996, Journal of applied physiology.

[12]  A. Valls-i-Soler,et al.  The effects of multiple small doses of exogenous surfactant on experimental respiratory failure induced by lung lavage in rats , 1995, Acta anaesthesiologica Scandinavica.

[13]  B. Lachmann,et al.  Dose‐response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS) , 1995, British journal of pharmacology.

[14]  F. Poulain,et al.  Pulmonary surfactant therapy. , 1995, The Western journal of medicine.

[15]  P. Germann,et al.  Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF. , 1994, Pulmonary pharmacology.

[16]  S. Hawgood,et al.  Lung function, surfactant apoprotein content, and level of PEEP in prematurely delivered rabbits. , 1994, Journal of applied physiology.

[17]  P. Richman,et al.  Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. , 1994, Chest.

[18]  A. Jobe,et al.  Surfactant and the adult respiratory distress syndrome. , 1993, The American review of respiratory disease.

[19]  C. R. Reed,et al.  Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. , 1991, The Journal of clinical investigation.

[20]  R. Spragg,et al.  Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury. , 1990, The American review of respiratory disease.

[21]  T. Pilot‐Matias,et al.  Two SP-C genes encoding human pulmonary surfactant proteolipid. , 1988, The Journal of biological chemistry.

[22]  B. Bhavnani,et al.  Effect of Reconstituted Pulmonary Surfactant Containing the 6000-Dalton Hydrophobic Protein on Lung Compliance of Prematurely Delivered Rabbit Fetuses , 1988, Pediatric Research.

[23]  J. Schilling,et al.  Low molecular weight human pulmonary surfactant protein (SP5): isolation, characterization, and cDNA and amino acid sequences. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Jörnvall,et al.  Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity. , 1987, European journal of biochemistry.

[25]  B. Robertson,et al.  The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant. , 1986, European journal of respiratory diseases.

[26]  B. Lachmann,et al.  Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage , 1986, Acta anaesthesiologica Scandinavica.

[27]  D. Strayer,et al.  Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. , 1983, The Journal of clinical investigation.

[28]  R. Spragg,et al.  Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. , 1982, The Journal of clinical investigation.

[29]  G. W. Paul,et al.  Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. , 1979, Chest.

[30]  G. Enhorning,et al.  Pulsating bubble technique for evaluating pulmonary surfactant. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.